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OBJECTIVE — Toinvestigatetherelationbetweentotalﬁsh,typeofﬁsh(leanandfatty),and
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake and risk of type 2 diabetes
in a population-based cohort.
RESEARCH DESIGN AND METHODS — The analysis included 4,472 Dutch partici-
pantsaged55yearswithoutdiabetesatbaseline.Dietaryintakewasassessedwithasemiquan-
titative food frequency questionnaire. Hazard ratios (relative risk [RR]) with 95% CIs were used
to examine risk associations adjusted for age, sex, lifestyle, and nutritional factors.
RESULTS — After 15 years of follow-up, 463 participants developed type 2 diabetes. Median
ﬁshintake,mainlyleanﬁsh(81%),was10g/day.Totalﬁshintakewasassociatedpositivelywith
risk of type 2 diabetes; the RR was 1.32 (95% CI 1.02–1.70) in the highest total ﬁsh group (28
g/day) compared with that for non–ﬁsh eaters (Ptrend  0.04). Correspondingly, lean ﬁsh intake
tendedtobeassociatedpositivelywithtype2diabetes(RRhighestgroup]23g/day]1.30[95%
CI 1.01–1.68]; Ptrend  0.06), but fatty ﬁsh was not. No association was observed between EPA
and DHA intake and type 2 diabetes (RR highest group [149.4 mg/day] 1.22 [0.97–1.53]).
Withadditionaladjustmentforintakeofselenium,cholesterol,andvitaminD,thisRRdecreased
to 1.05 (0.80–1.38; Ptrend  0.77).
CONCLUSIONS — The ﬁndings do not support a beneﬁcial effect of total ﬁsh, type of ﬁsh,
or EPA and DHA intake on the risk of type 2 diabetes. Alternatively, other dietary components,
such as selenium, and unmeasured contaminants present in ﬁsh might explain our results.
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otential beneﬁts of the intake of ﬁsh
on the development of type 2 diabe-
tes could be attributed to its high
content of dietary n-3 polyunsaturated
fatty acids, speciﬁcally eicosapentaenoic
acid (EPA) and docosahexaenoic acid
(DHA). Higher EPA and DHA quantities
in the phospholipid cell membranes
could increase insulin sensitivity (1). EPA
and DHA supplementation increased in-
sulin sensitivity in animal models and in
some human studies (2). Results of pro-
spective studies on intake of long-chain
n-3 fatty acids and type 2 diabetes risk,
however, did not show a relation (3,4).
Apart from EPA and DHA, other compo-
nents within ﬁsh, such as selenium and
vitamin D, could also be related to type 2
diabetes. Vitamin D could be negatively
and selenium could be positively associ-
ated with type 2 diabetes (5,6).
Resultsofstudiesthatinvestigatedthe
associationbetweenﬁshintakeandtype2
diabetes risk are inconclusive. An ecolog-
ical study reported that high ﬁsh intake
may reduce the risk of type 2 diabetes in
populations with a high prevalence of
obesity (7). Cross-sectional studies re-
ported inverse (8,9), no (10,11), or posi-
tive (12) associations between habitual
ﬁsh intake and glycemic status. Prospec-
tive evidence suggested that ﬁsh intake is
either inversely (13,14) or not associated
(15) with the risk of type 2 diabetes.
Taken together, the effects of ﬁsh in-
take and EPA and DHA intake on the
development of type 2 diabetes are am-
biguous.Furthermore,studiesconducted
in this ﬁeld did not report associations
between different types of ﬁsh and type 2
diabetes risk. EPA and DHA are present
mainly in fatty ﬁsh, which might indicate
thatitisalsoimportanttopayattentionto
thetypeofﬁshthatiseateninsteadoftotal
ﬁsh intake alone.
Therefore, we investigated the rela-
tion between the intake of total ﬁsh, type
of ﬁsh (lean or fatty), and EPA and DHA
andtype2diabetesriskinapopulationof
men and women aged 55 years. We hy-
pothesized that ﬁsh intake and especially
fatty ﬁsh intake is related inversely to the
risk of type 2 diabetes.
RESEARCH DESIGN AND
METHODS— The current study was
conducted within the Rotterdam Study,
anongoingprospectivepopulation-based
study, which has been described in detail
elsewhere (16). In short, 7,983 inhabit-
antswhoresidedinthedistrictOmmoord
of Rotterdam, the Netherlands, and were
aged 55 years agreed to participate (re-
sponse rate 78%). Our study population
consisted of 4,472 participants because
participants without (n  2,339) or with
unreliable (n  209) dietary data, those
with known or newly diagnosed diabetes
at baseline (n  516), and those who had
not sufﬁcient clinical or anthropometric
data (n  447) were excluded. The Med-
icalEthicsCommitteeofErasmusMedical
Center (Rotterdam, the Netherlands) ap-
provedthestudy.Allparticipantsgavein-
formed consent.
Baseline information
Baseline information on current health
status was obtained by a questionnaire
and clinical examinations between 1990
and 1993. Anthropometric information
wasobtainedduringavisittotheresearch
center. BMI was calculated from height
and weight (weight in kilograms divided
by the square of height in meters). Waist
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sured at the level midway between the
lower rib margin and the iliac crest with
participants in the standing position.
Blood pressure was measured at the right
brachial artery with a random-zero
sphygmomanometer with the partici-
pants in a sitting position. The mean of
two consecutive measurements was used.
Hypertension was deﬁned as systolic
blood pressure 140 mmHg and/or
diastolic blood pressure 90 mmHg
and/or use of blood pressure–lowering
medication.
Blood samples were used to de-
termine serum total cholesterol by an
automated enzymatic procedure using
CHOD-PAP reagent (Roche Diagnostics).
HDL cholesterol was measured with an
HDL cholesterol assay (Roche Diagnos-
tics) using polyethylene glycol–modiﬁed
enzymes and dextran sulfate. A history
ofcoronaryheartdisease(CHD)wasde-
ﬁned as a self-reported myocardial in-
farctionoranginapectoriswithhospital
admission. A family history of type 2
diabetes was deﬁned as having a par-
ent, sibling, or both with type 2
diabetes.
For a subsample of the population
(n  2,424), the physical activity level
was measured with a physical activity
questionnaire (LASA Physical Activity
Questionnaire) between 1997 and 2000
(17). Body weight, hours of different ac-
tivities,andthecorrespondingMETscore
wereusedtocalculateenergyexpenditure
(kilocalories per day).
Dietary intake
Dietary assessment comprised a self-
administered questionnaire followed by a
structured interview with a trained dieti-
tian at the research center. Participants
had to mark the foods and drinks they
had consumed at least twice a month in
the preceding year. Subsequently, the di-
etitian obtained accurate information on
the amount of food eaten using a vali-
dated 170–food item semiquantitative
food frequency questionnaire (18). Food
intake data were converted to energy and
nutrient intake using a Dutch Food Com-
position table (1993). For intake of EPA,
DHA, and trans fatty acids, a later version
was used (2006). The amounts of energy
from total fat and saturated fat, carbohy-
drates, and protein were calculated as a
percentage of total energy intake (energy
percent).
Total ﬁsh intake (grams per day) was
dividedintofourcategories:noﬁshintake
and approximate tertiles of ﬁsh consum-
ers. The variables lean ﬁsh (i.e., plaice,
stockﬁsh, cod, ﬁsh ﬁngers, perch, pike,
octopus,pollack,tuna,andsole)andfatty
ﬁsh (i.e., mackerel, herring, eel, and
salmon) were categorized in the same
way. Shellﬁsh intake (i.e., mussels and
shrimp) was dichotomized. Participants
were categorized as fried ﬁsh eaters when
theyatepollackorcod.TheintakeofEPA
and DHA (milligrams per day) was di-
vided into tertiles.
Follow-up information
Participants were continuously moni-
tored for major events using the informa-
tion from general practitioners and
pharmacy databases. Information on vital
status was obtained regularly from the
municipal health authorities in Rotter-
dam. With this information follow-up
datacouldbecensoredattimeofdeathfor
1,337 (30%) participants.
Incident diabetes cases were deﬁned
accordingtotheAmericanDiabetesAsso-
ciation 1997 criteria and the World
HealthOrganization1999criteria(fasting
plasma glucose level 7.0 mmol/l and/or
random plasma glucose level 11.1
mmol/l and/or use of antidiabetes medi-
cation and/or treatment by diet) and reg-
istered by a general practitioner as having
diabetes. Follow-up data were available
until July 2005.
Statistical analysis
To compare baseline characteristics
across ﬁsh intake categories we used
ANOVA for continuous variables and 
2
tests for categorical variables. Hazard ra-
tios (relative risk [RR]) and 95% CIs were
calculated to investigate the association
between incident type 2 diabetes and 1)
total ﬁsh intake, 2) lean ﬁsh intake, 3)
fatty ﬁsh intake, and 4) EPA and DHA
intake. Non–ﬁsh consumers, noncon-
sumersofleanorfattyﬁsh(irrespectiveof
their other ﬁsh consumption), and low
intake of EPA and DHA were considered
as the reference group, respectively.
To evaluate whether the risk of type 2
diabetes differed among the intake cate-
gories we performed Cox proportional
hazard analyses. In the crude model no
adjustmentsweremade.Intheﬁrstmodel
adjustments were made for age (years),
sex, smoking (never, former, or current),
and level of education (low [primary ed-
ucation], intermediate [lower vocational,
secondary general, or vocational educa-
tion], or high [higher vocational educa-
tion or university]). The second model
was additionally adjusted for dietary fac-
tors,i.e.,intakeofenergy(kilocaloriesper
day), trans fatty acids (grams per day), ﬁ-
ber (grams per day), and alcohol (no, low
[0–3 g/day], medium [3–14 g/day], or
high [14 g/day]). For lean ﬁsh intake as
exposure,fattyﬁshwasincludedasacon-
founder in the model and vice versa. To
investigate whether other components
present in ﬁsh confounded the associa-
tion between EPA and DHA intake and
type 2 diabetes, for this association only
model 2 was additionally adjusted for in-
take of selenium (micrograms per day),
vitaminD(microgramsperday),andcho-
lesterol (milligrams per day). Other po-
tential confounders including family
history of diabetes, medically prescribed
diet, and intake of saturated fat, monoun-
saturated fat, linoleic acid, -linolenic
acid, fruit, vegetables, coffee, and meat
were examined but did not affect the re-
sults. Potential effect modiﬁcation by sex
was tested.
In additional analysis, the potential
intermediates, i.e., BMI (kilograms di-
vided by meters squared), waist circum-
ference (centimeters), total and HDL
cholesterol (millimoles per liter), and hy-
pertension (no or yes), were investigated.
A linear test for trend across categories
was performed based on the median val-
ues of each category. All statistical analy-
ses were performed using the statistical
program SAS 9.1 for Windows. For all
analyses a two-sided P value  0.05 was
considered statistically signiﬁcant.
RESULTS— The study population
consisted of 4,472 participants with an
average age of 67.2  7.7 years at base-
line. Median follow-up time was 12.4
years during which 463 (10%) incident
cases of type 2 diabetes were diagnosed.
Mean age of diabetes onset was 73.9 
6.9 years. Fifteen participants (0.3%)
used ﬁsh oil capsules, and 475 (11%)
were consuming a prescribed diet.
Zero ﬁsh intake was reported by 29%
of the population (Table 1). Median ﬁsh
intake in the total population was 10
g/day. The ﬁsh consumed consisted on
average of 81% lean ﬁsh, 18% fatty ﬁsh,
and 0.9% shellﬁsh. Of the nonconsumers
of lean ﬁsh, 88% were also nonconsumers of
fattyﬁshand43%ofthenonconsumersof
fatty ﬁsh were also nonconsumers of lean
ﬁsh. Lean ﬁsh consumers ate 19  15
g/day, fatty ﬁsh consumers ate 9.1  12
g/day, and shellﬁsh consumers ate 4.8 
5.0g/dayonaverageofleanﬁsh,fattyﬁsh,
and shellﬁsh, respectively. Median intake
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mg/day. Spearman correlation between
intake of total ﬁsh and EPA and DHA was
0.87 (P  0.01). Participants with higher
total ﬁsh intake were younger, had higher
total cholesterol levels, and were more
likelytodrinkalcohol(Table1).Intakeof
trans fatty acids was lower in these partic-
ipants, whereas the intake of ﬁber, cho-
lesterol, selenium, and vitamin D was
higher (P  0.05 for all variables). Fish
intake contributed 13, 12, and 5% to the
total intake of selenium, vitamin D, and
cholesterol, respectively.
In contrast to our hypothesis, we ob-
served a positive association for total ﬁsh
intakeanddiabetesrisk(Table2).TheRR
for those in the highest group of total ﬁsh
intake compared with that for the non–
ﬁsh eaters was 1.32 (95% CI 1.02–1.70;
Ptrend  0.04) when adjusted for lifestyle
and dietary factors (model 2). When fur-
ther adjusted for the intake of fried ﬁsh
(no or yes), total ﬁsh intake was border-
line signiﬁcant (RR in the highest group
1.26 [95% CI 0.97–1.64]; Ptrend  0.06).
When analyses were stratiﬁed for
types of ﬁsh, lean ﬁsh intake tended to be
associated with a higher risk (RR 1.30
[95% CI 1.01–1.68; Ptrend  0.06]),
whereas fatty ﬁsh did not (0.99 [0.71–
1.38]). No signiﬁcant associations were
found for shellﬁsh consumers in any
Table 1—Baseline characteristics of 4,472 Dutch adults aged >55 years across categories of total ﬁsh intake
Characteristics
Fish intake
P No
Low
(0–12 g/day)
Moderate
(12–28 g/day) High (28 g/day)
n 1,314 1,061 1,007 1,090
Age (years) 67.8  8.1 67.6  7.5 66.8  7.5 66.6  7.4 0.001
Follow-up (years) 10.9  3.7 10.8  3.6 11.0  3.4 10.8  3.6 0.70
Men (%) 38.6 41.9 41.1 42.9 0.16
BMI (kg/m
2) 26.1  3.5 26.3  3.7 26.4  3.8 26.2  3.4 0.31
Waist circumference (cm) 89.1  11.0 90.1  11.0 90.0  10.9 89.8  11.0 0.10
Smokers (%) 0.004
Current 21.8 24.6 22.2 24.0
Former 40.6 43.4 43.1 46.2
Never 37.6 32.1 34.7 29.8
Family history of diabetes (%) 28.2 27.6 26.9 27.9 0.92
History of CHD (%) 11.7 12.7 13.5 10.9 0.28
Hypertension (%) 29.8 32.0 32.7 31.0 0.46
Cholesterol (mmol/l)
Total cholesterol 6.6  1.3 6.7  1.1 6.7  1.2 6.8  1.2 0.02
HDL cholesterol 1.4  0.36 1.4  0.35 1.4  0.36 1.4  0.40 0.30
Educational level (%) 0.001
Low 35.5 37.5 31.6 30.9
Intermediate 54.9 51.7 54.9 53.2
High 9.6 10.8 13.5 15.9
Diet prescription (%) 9.6 11.1 11.1 10.9 0.55
Dietary intake
Energy (kcal/day) 1,962  485 1,953  503 1,989  524 2,025  521 0.004
Carbohydrates (energy %) 45.1  7.1 44.1  7.0 43.9  6.8 43.3  6.8 0.001
Protein (energy %) 16.5  3.0 16.8  2.9 17.2  3.1 17.8  3.1 0.001
Total fat (energy %) 36.7  6.4 36.9  6.1 36.5  6.1 35.9  6.1 0.001
Saturated fatty acids (energy %) 14.8  3.2 14.6  3.1 14.2  3.1 14.0  3.3 0.001
Trans fatty acids (energy %) 1.3  0.48 1.3  0.48 1.2  0.43 1.2  0.45 0.001
EPA and DHA (mg/day)* 25.2 (13.0–40.7) 63.5 (39.5–95.4) 132 (100–188) 245 (182–374) 0.001
Fiber (g/day) 16.6  5.0 16.8  5.3 17.1  5.3 17.2  5.0 0.02
Cholesterol (mg/day) 225  80.8 226  79.5 233  80.3 251  85.7 0.001
Selenium (g/day) 27.3  7.4 29.5  7.6 33.4  8.1 41.7  11.3 0.001
Vitamin D (g/day) 1.9  1.2 2.0  1.2 2.2  1.4 2.6  1.8 0.001
Alcohol (%) 0.001
No 23.8 20.4 15.4 16.8
Low 29.5 30.5 29.7 24.3
Moderate 26.1 24.4 26.8 26.0
High 20.6 24.7 28.1 32.9
Fish (g/day)
Lean 0 5.1  3.3 14.8  5.5 33.6  15.9 0.001
Fatty 0 1.3  2.3 2.9  4.7 7.7  14.0 0.001
Shellﬁsh 0 0.08  0.51 0.21  1.3 0.32  2.0 0.001
Data are means  SD or % unless otherwise indicated. *Value expressed as median (interquartile range) because of skewed distribution.
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shellﬁsh(RRmodel21.04[95%CI0.61–
1.77]) (data not shown).
Furthermore, no associations were
observed for EPA and DHA intake (Table
3). The RR was 1.22 (95% CI 0.97–1.53)
for the highest level of EPA and DHA in-
take compared with the lowest. Addi-
tional adjustments for intake of selenium,
vitamin D, and cholesterol decreased the
RR to 1.05 (0.80–1.38).
In a subsample (n  2,424), energy
expenditure was added to model 2, but
the RRs did not change appreciably (data
not shown). Furthermore, when BMI and
waist circumference were taken into ac-
count in addition to model 2, the RRs did
not alter substantially (RR highest total
ﬁsh intake 1.29 [95% CI 1.00–1.67]).
Theotherpotentialintermediates,i.e.,to-
tal cholesterol, HDL cholesterol, and hy-
pertension, did not change any of the RRs
either. Sex did not modify the observed
relations (RR highest total ﬁsh intake for
men 1.38 [0.94–2.02] and for women
1.26 [0.90–1.78]). In all analyses, after
exclusion of participants with previous
CHD at baseline (n  544), those who
consumed ﬁsh oil capsules (n  15), or
those who did not eat ﬁsh or meat (n 
18)separately,theresultsdidnotchange.
CONCLUSIONS — The results of
thisprospectivestudyinolderDutchmen
and women with a low habitual level of
ﬁsh intake do not support the hypothesis
that ﬁsh intake could protect against risk
of type 2 diabetes. On the contrary, we
observed a positive association between
total ﬁsh intake and type 2 diabetes. This
result was mainly due to lean ﬁsh intake,
which accounted for 81% of total ﬁsh in-
take. Intake of fatty ﬁsh and EPA and
DHA was not related to type 2 diabetes
risk.
In this study, it is unlikely that the
association was obscured because of mis-
classiﬁcation of diabetes incidence. Onset
of diabetes was monitored continuously
through general practitioners and fol-
low-up visits. The extensive information
Table 3—RRs (95% CIs) for incident type 2 diabetes by tertiles of EPA and DHA intake in
4,472 Dutch adults aged >55 years
Tertiles of EPA and DHA intake (mg/day)
Ptrend
Low
(49.1 mg/day)
Moderate
(49.1–149.4 mg/day)
High
(149.4 mg/day)
Median intake 23.8 89.4 236.8
No. participants/cases 1,490/142 1,491/158 1,491/163
Person-years 16,085 16,303 16,263
Crude model 1 1.09 (0.87–1.37) 1.12 (0.89–1.40) 0.38
Model 1 1 1.10 (0.88–1.38) 1.13 (0.90–1.42) 0.33
Model 2 1 1.13 (0.90–1.42) 1.22 (0.97–1.53) 0.11
Model 3 1 1.06 (0.84–1.34) 1.05 (0.80–1.38) 0.77
Data are RRs (95% CIs). Model 1: adjusted for age, sex, smoking, and education level. Model 2: as model 1
with additional adjustments for intake of energy, alcohol, trans fatty acids, and ﬁber. Model 3: as model 2
with additional adjustments for intake of selenium, vitamin D, and cholesterol.
Table 2—RRs (95% CIs) for incident type 2 diabetes by ﬁsh intake categories in 4,472 Dutch adults aged >55 years
Total ﬁsh
Categories of ﬁsh intake
Ptrend No Low (0–12 g/day) Moderate (12–28 g/day) High (28 g/day)
Median intake 0 6.6 17.5 35.6
No. participants/cases 1,314/121 1,061/112 1,007/107 1,090/123
Person-years 14,267 11,492 11,073 11,819
Crude model 1 1.15 (0.89–1.49) 1.13 (0.87–1.47) 1.22 (0.95–1.56) 0.18
Model 1 1 1.14 (0.88–1.47) 1.14 (0.88–1.48) 1.23 (0.96–1.58) 0.14
Model 2 1 1.15 (0.89–1.48) 1.19 (0.92–1.54) 1.32 (1.02–1.70) 0.04
Lean ﬁsh* No Low (0–10 g/day) Moderate (10–23 g/day) High (23 g/day) Ptrend
Median intake 0 6.5 14.3 30.6
No. participants/cases 1,488/139 992/110 992/99 1,000/115
Person-years 16,119 10,769 10,974 10,788
Crude model 1 1.18 (0.92–1.52) 1.03 (0.80–1.34) 1.22 (0.96–1.57) 0.19
Model 1 1 1.17 (0.90–1.51) 1.05 (0.81–1.37) 1.24 (0.96–1.60) 0.16
Model 2 1 1.15 (0.89–1.49) 1.07 (0.82–1.40) 1.30 (1.01–1.68) 0.06
Fatty ﬁsh* No Low (0–3 g/day) Moderate (3–7 g/day) High (7 g/day) Ptrend
Median intake 0 1.6 5.3 15.7
No. participants/cases 3,087/313 461/51 499/57 425/42
Person-years 33,586 5,124 5,329 4,612
Crude model 1 1.05 (0.78–1.42) 1.14 (0.86–1.51) 0.97 (0.70–1.34) 0.98
Model 1 1 1.01 (0.74–1.36) 1.07 (0.80–1.43) 0.92 (0.66–1.28) 0.70
Model 2 1 1.04 (0.77–1.42) 1.11 (0.83–1.49) 0.99 (0.71–1.38) 0.93
DataareRRs(95%CIs).Model1:adjustedforage,sex,smoking,andeducationlevel.Model2:asmodel1withadditionaladjustmentsforintakeofenergy,alcohol,
trans fatty acids, and ﬁber. *Models 1 and 2: lean ﬁsh is adjusted for fatty ﬁsh; fatty ﬁsh is adjusted for lean ﬁsh.
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mized the possibility of residual con-
founding, also strengthened our results.
Information about physical activity was
available for only a subsample of the pop-
ulation. Adjustment for energy expendi-
ture did not affect the RR, through which
itisunlikelythatconfoundingbyphysical
activity explained our results. Another
strengthofourstudyisthelargereference
group,whichenabledustoshowanasso-
ciation,ifonewouldhaveexisted.Within
ﬁsh eaters, however, the contrast of ﬁsh
intake appeared to be small. The total ﬁsh
intake is rather low (10 g/day) in this
population, which limited the possibility
of studying the effects of high ﬁsh intake
on diabetes onset. Furthermore, the in-
vestigation into the effect of fatty ﬁsh in-
takemighthavebeenrestrictedbecauseof
thehighintakeofleanﬁshrelativetofatty
ﬁsh. We cannot rule out potential mis-
classiﬁcationofﬁshintakeduetochanges
inﬁshintakeduringfollow-up.However,
participants with type 2 diabetes or CHD
atbaselinewhowerelikelytochangetheir
diet as a consequence of disease were ex-
cluded or did not change the results,
respectively.
Incontrastwithourﬁndings,twoear-
lier cohort studies showed protective ef-
fects of ﬁsh intake (13,14). The study of
Feskensetal.(13),whichshowedanodds
ratioof0.47forﬁsheaterscomparedwith
non–ﬁsh eaters, was smaller (59 cases)
and had a shorter follow-up period (4
years) than our study. In the Dutch and
Finnish cohorts of the Seven Countries
Study, which used 2-h blood glucose lev-
els instead of type 2 diabetes risk, a
change in ﬁsh intake was also associated
with a reduced risk (	 0.18) (14). In
the Nurses Health Study II an association
between ﬁsh intake and risk of type 2 di-
abetes was not found (RR 2 portions/
week vs. 1 portion/week 1.04) (15).
Differences in range, type, and prepara-
tion of ﬁsh might explain in part the ob-
serveddifferencesinriskestimatesamong
studies.
Concerning n-3 fatty acids, in line
with our study two other prospective
studies also showed no association. In the
Health Professionals Follow-up Study
(3), an RR of 1.01 (upper vs. lower quin-
tile)wasobserved,andtheIowaWomen’s
Health Study (4) showed an RR of 1.11
between the upper and lower quintiles of
long-chain n-3 fatty acid intake and dia-
betes risk.
Thedifferentﬁndingsbetweenthein-
takes of ﬁsh and EPA and DHA might be
partly explained by the intake of deep-
fried ﬁsh that is generally lean ﬁsh. Deep-
fat frying can affect the potential beneﬁts
ofﬁshbyloweringtheEPAandDHAcon-
tent(19).Indeed,althoughdetailedinfor-
mation on the preparation method was
not available, after additional adjustment
for fried ﬁsh intake, the RR decreased for
the highest total ﬁsh intake category in
our cohort.
Furthermore, the potential beneﬁcial
effect of EPA and DHA intake could be
counteracted by total cholesterol intake,
which was associated signiﬁcantly with
ﬁsh intake in our study. Elevated choles-
terol levels may impair pancreatic -cell
function and insulin secretion (20). It
should be noted, however, that when ad-
ditional adjustments were made for in-
takeofcholesterol,selenium,andvitamin
D, the RR for the highest intake group of
EPA and DHA compared with the lowest
groupwasespeciallyreducedafteradjust-
ment for selenium intake. Plasma sele-
nium levels increase with increasing ﬁsh
intake(21)andmayincreasediabetesrisk
(22). Selenium supplementation in-
creased diabetes risk in a trial among
1,202 dermatology patients (6) and
tended to increase diabetes risk in the Se-
lenium and Vitamin E Cancer Prevention
Trial (SELECT) including 35,533 men
(23). An adverse effect of selenium on di-
abetes risk might therefore explain the
higher risk in the highest total ﬁsh and
EPA and DHA intake groups.
Finally, particularly at high exposure
levels, it may be that the potential beneﬁ-
cial effect of EPA and DHA was counter-
acted by ingestion of contaminated ﬁsh,
especiallyleanfreshwaterﬁsh.Micemod-
els showed that elevated blood mercury
levels decreased plasma insulin and ele-
vated blood glucose levels (24). Serum
concentrations of persistent organic pol-
lutants were strongly related with diabe-
tes prevalence in a cross-sectional study
(25). Unfortunately, we do not have in-
formation available on intake of contam-
inants in the current study.
In summary, the ﬁndings of this pro-
spectivestudydonotsupportaprotective
effect of total ﬁsh, type of ﬁsh, nor EPA
and DHA intake on the development of
type 2 diabetes. Total ﬁsh intake even ap-
peared to be positively associated with
risk of type 2 diabetes in this study. Di-
etary components and contaminants
present in ﬁsh should be studied exten-
sivelywhenthepotentialroleofﬁshinthe
development of type 2 diabetes is exam-
ined further. At this point, given the con-
ﬂicting results on ﬁsh intake and type 2
diabetes risk, we think it is too early to
give recommendations regarding ﬁsh in-
take in relation to type 2 diabetes.
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